Literature DB >> 17133215

Renal function in patients receiving tenofovir with ritonavir/lopinavir or ritonavir/atazanavir in the HIV Outpatient Study (HOPS) cohort.

Kate Buchacz, Benjamin Young, Rose K Baker, Anne Moorman, Joan S Chmiel, Kathy C Wood, John T Brooks.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17133215     DOI： 10.1097/01.qai.0000242461.35768.45

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  11 in total

1.  Renal events among women treated with tenofovir/emtricitabine in combination with either lopinavir/ritonavir or nevirapine.

Authors:  Albert Mwafongo; Kondwani Nkanaunena; Yu Zheng; Evelyn Hogg; Wadzanai Samaneka; Lloyd Mulenga; Abraham Siika; Judith Currier; Shahin Lockman; Michael D Hughes; Mina Hosseinipour
Journal:  AIDS       Date:  2014-05-15       Impact factor: 4.177

Review 2.  Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?

Authors:  Jérôme Tourret; Gilbert Deray; Corinne Isnard-Bagnis
Journal:  J Am Soc Nephrol       Date:  2013-09-19       Impact factor: 10.121

3.  Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.

Authors:  Eric S Daar; Camlin Tierney; Margaret A Fischl; Paul E Sax; Katie Mollan; Chakra Budhathoki; Catherine Godfrey; Nasreen C Jahed; Laurie Myers; David Katzenstein; Awny Farajallah; James F Rooney; Keith A Pappa; William C Woodward; Kristine Patterson; Hector Bolivar; Constance A Benson; Ann C Collier
Journal:  Ann Intern Med       Date:  2011-02-14       Impact factor: 25.391

Review 4.  The nephrotoxic effects of HAART.

Authors:  Hassane Izzedine; Marianne Harris; Mark A Perazella
Journal:  Nat Rev Nephrol       Date:  2009-10       Impact factor: 28.314

5.  Renal function with use of a tenofovir-containing initial antiretroviral regimen.

Authors:  Joel E Gallant; Richard D Moore
Journal:  AIDS       Date:  2009-09-24       Impact factor: 4.177

6.  Tenofovir nephrotoxicity: 2011 update.

Authors:  Beatriz Fernandez-Fernandez; Ana Montoya-Ferrer; Ana B Sanz; Maria D Sanchez-Niño; Maria C Izquierdo; Jonay Poveda; Valeria Sainz-Prestel; Natalia Ortiz-Martin; Alejandro Parra-Rodriguez; Rafael Selgas; Marta Ruiz-Ortega; Jesus Egido; Alberto Ortiz
Journal:  AIDS Res Treat       Date:  2011-06-07

7.  Tenofovir-associated renal dysfunction in clinical practice: An observational cohort from western India.

Authors:  Ketan K Patel; Atul K Patel; Rajiv R Ranjan; Apurva R Patel; Jagdish K Patel
Journal:  Indian J Sex Transm Dis AIDS       Date:  2010-01

Review 8.  Kidney Disease in HIV Infection.

Authors:  Gaetano Alfano; Gianni Cappelli; Francesco Fontana; Luca Di Lullo; Biagio Di Iorio; Antonio Bellasi; Giovanni Guaraldi
Journal:  J Clin Med       Date:  2019-08-19       Impact factor: 4.241

9.  Impact of a tenofovir disoproxil fumarate plus ritonavir-boosted protease inhibitor-based regimen on renal function in HIV-infected individuals: a prospective, multicenter study.

Authors:  Ying Cao; Yang Han; Jing Xie; Qu Cui; Lixia Zhang; Yijia Li; Yanling Li; Xiaojing Song; Ting Zhu; Taisheng Li
Journal:  BMC Infect Dis       Date:  2013-07-01       Impact factor: 3.090

Review 10.  A review of cardiovascular and renal function monitoring: a consideration of older adults with HIV.

Authors:  Clark D Kebodeaux; Alexandria Garavaglia Wilson; Daron L Smith; Scott Martin Vouri
Journal:  HIV AIDS (Auckl)       Date:  2013-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.